Literature DB >> 5104016

The efficacy of dietary therapy for phenylketonuria.

W B Hanley, L S Linsao, C Netley.   

Abstract

Ninety-four patients with classical phenylketonuria are reviewed. Early treatment with a low phenylalanine diet usually results in normal or near-normal I.Q. Twenty-seven of the 38 patients diagnosed before 2 months of age have an I.Q. in the normal range. Of the other 11, six are dull normal, four are borderline and one is frankly retarded. Adequate reasons are given for the less than optimal results in these 11 early-treated patients. Twenty-one of the 28 patients presenting with abnormal electroencephalograms showed normal tracings soon after initiation of diet and four of the other seven improved. Nine of 12 on continuous anticonvulsant medication at the time of presentation were able to discontinue this soon after institution of dietary measures. Eighteen of the 19 sibling pair comparisons revealed a better ultimate I.Q. in the early-treated sib. A plea for early diagnosis by continuation of newborn screening programs and for centralization of diagnostic confirmation and treatment is made.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5104016      PMCID: PMC1931028     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Mental testing of children under three years.

Authors:  S OPPENHEIMER; J W KESSLER
Journal:  Pediatrics       Date:  1963-05       Impact factor: 7.124

2.  Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet.

Authors:  I M Hackney; W B Hanley; W Davidson; L Lindsao
Journal:  J Pediatr       Date:  1968-05       Impact factor: 4.406

3.  Another population of phenylketonuria? Studies on atypical phenylketonurics.

Authors:  P D Culley
Journal:  Dev Med Child Neurol       Date:  1969-12       Impact factor: 5.449

4.  Variability in the manifestations of phenylketonuria.

Authors:  G Pineda
Journal:  J Pediatr       Date:  1968-04       Impact factor: 4.406

5.  Heterogeneity in genetic control of phenylalanine metabolism in man.

Authors:  D Rosenblatt; C R Scriver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

6.  Atypical phenylketonuria with borderline or normal intelligence.

Authors:  D Y Hsia; M E O'Flynn; J L Berman
Journal:  Am J Dis Child       Date:  1968-08

7.  Glutamine depletion in phenylketonuria. A possible cause of the mental defect.

Authors:  T L Perry; S Hansen; B Tischler; R Bunting; S Diamond
Journal:  N Engl J Med       Date:  1970-04-02       Impact factor: 91.245

8.  Phenylketonuria: intellectual developmental and early treatment.

Authors:  D J O'Grady; H K Berry; B S Sutherland
Journal:  Dev Med Child Neurol       Date:  1970-06       Impact factor: 5.449

9.  Legislation and advances in medical knowledge--acceleration or inhibition?

Authors:  S P Bessman
Journal:  J Pediatr       Date:  1966-08       Impact factor: 4.406

10.  Evaluation of the effects of terminating the diet in phenylketonuria.

Authors:  G Solomons; L Keleske; E Opitz
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

View more
  3 in total

1.  Maternal Phenylketonuria (MPKU).

Authors:  W E Schoonheyt; W B Hanley; J T Clarke; V Austin; D A Howe
Journal:  Can Fam Physician       Date:  1986-10       Impact factor: 3.275

2.  [Urinary phenylalanine metabolites in hyperphenylalaninemia (author's transl)].

Authors:  P Koepp
Journal:  Klin Wochenschr       Date:  1976-11-01

3.  Phenylketonuria and its variants: observations on intellectual functioning.

Authors:  C Netley; W B Hanley; H L Rudner
Journal:  Can Med Assoc J       Date:  1984-10-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.